Seattle Children's opens pediatric immunotherapy research facility

Listen
Text
  • Small
  • Medium
  • Large

Seattle Children's announced on Oct. 15 the opening of its Building Cure biomedical research center in the "biotech corridor" of downtown Seattle.

The 540,000-square-foot facility comprises 10 floors of biomedical laboratory space, in which researchers will develop investigational immunotherapies and other cell therapies to treat pediatric cancer. Building Cure is also home to the new Cure Factory, which can manufacture cancer-fighting T cells and other cell therapies for up to 1,000 children per year.

Building Cure's opening expands the Seattle Children's research campus to span more than 1.1 million square feet. Also contained in the facility are a Science Discovery Lab, in which students can conduct real experiments in immunotherapy, gene editing and infectious disease research alongside the hospital's researchers, and extra lab spaces that will be developed over time in accordance with changing research needs and technological advances.

"It's an exciting time for science in Seattle, a city known worldwide for its contributions to technology and innovation," said Jeff Sperring, MD, CEO of Seattle Children's. "Building Cure will not only help today's researchers fulfill our mission to help every child live the healthiest and most fulfilling life possible, but also inspire future generations of scientists to bring more cures to more children faster."

More articles on innovation:
4 San Antonio research institutions team up for precision health innovation
The innovation that's worth the investment: Q&A with Lehigh Valley Health Network CIO
Virginia Tech launches $1.5B fundraising campaign for innovation campus

Copyright © 2021 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars